Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abate, absolute, alleged, Amsterdam, anin, ASC, authoritative, baseline, Bill, burden, capped, categorized, CFO, CIRM, Codification, collusion, commensurate, correlative, culmination, cumulative, curve, customer, density, digit, element, embryonic, entirety, ESPP, exam, expansion, faith, fiber, Grand, guidanceon, IENFD, improper, intraepidermal, judgment, lengthen, licensee, literature, Melinda, nonrefundable, objective, reevaluate, reevaluation, refractory, regrowth, rendered, renewed, sixty, skin, source, subgroup, thirty, Topline, transposase, Treasury, unmyelinated, upheaval, Vendor
Removed:
accounted, APB, assuming, attestation, avoiding, Brewery, brought, Bulletin, Canada, Casey, caution, cautionary, circumvention, closure, communicated, comparison, deducting, error, exclude, FAS, FIN, Force, forfeiture, forma, infecting, interpretation, issuing, JHU, Kirin, lack, leader, likelihood, liu, margaret, Monetary, nonqualified, Nordisk, Novo, overriding, partial, participate, prescribed, pro, reinvestment, removed, represent, SAB, Separation, strong, Task, TFsTM, translation, TSRI, underwriter, unregistered, wood, ZFNsTM
Filing tables
Filing exhibits
- 10-K Annual report
- 10.8 Second Amendment to Patent License Agreement
- 10.9 Amendment No. 2 to License Agreement
- 10.10 Third Amendment to Patent License Agreement
- 10.11 Fourth Amendment to Patent License Agreement
- 10.12 Amendment No. 3 to License Agreement
- 10.13 License Agreement
- 10.14 Fifth Amendment to Patent License Agreement
- 10.17 Sixth Amendment to Patent License Agreement
- 10.20 Seventh Amendment to Patent License Agreement
- 10.21 First Amendment of Research and Commercial Option License Agreement
- 10.23 Eighth Amendment to Patent License Agreement
- 10.25 Amendment No. 4 to License Agreement
- 10.32 Amendment to License Agreement
- 10.39 Second Amendment of Research and Commercial Option License Agreement
- 10.40 Third Amendment of Research and Commercial Option License Agreement
- 10.44 First Amendment to the Research, Development and Commercialization Agreement
- 10.45 Fourth Amendment of Research and Commercial Option License Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Rule 13A-14(A) Certification of Chief Executive Officer
- 31.2 Rule 13A-14(A) Certification of Principal Financial Officer
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350
Related press release
SGMO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-157733, 333-34196, 333-64642 and 333-132823) and in the Registration Statements (Form S-3 No. 333-157732) and in the related prospectuses of Sangamo BioSciences, Inc. of our reports dated March 5, 2010, with respect to the consolidated financial statements of Sangamo BioSciences, Inc., and the effectiveness of internal control over financial reporting of Sangamo BioSciences, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2009.
/s/ ERNST & YOUNG LLP
Palo Alto, California
March 5, 2010